This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994;12(5):530-42.

doi: 10.3109/07357909409021413.

Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors

Y Pommier¹, F Leteurtre, M R Fesen, A Fujimori, R Bertrand, E Solary, G Kohlhagen, K W Kohn

Affiliations

PMID: 7922710
DOI: 10.3109/07357909409021413

Review

Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors

Y Pommier et al. Cancer Invest. 1994.

. 1994;12(5):530-42.

doi: 10.3109/07357909409021413.

Authors

Y Pommier¹, F Leteurtre, M R Fesen, A Fujimori, R Bertrand, E Solary, G Kohlhagen, K W Kohn

Affiliation

¹ Laboratory of Molecular Pharmacology (DTP, DCT), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

PMID: 7922710
DOI: 10.3109/07357909409021413

No abstract available

PubMed Disclaimer

Similar articles

The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E. Dubrez L, et al. Leukemia. 1995 Jun;9(6):1013-24. Leukemia. 1995. PMID: 7596166
Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
Solary E, Bertrand R, Pommier Y. Solary E, et al. Leuk Lymphoma. 1994 Sep;15(1-2):21-32. doi: 10.3109/10428199409051674. Leuk Lymphoma. 1994. PMID: 7858500 Review.
Cellular resistance to topoisomerase poisons.
Rubin EH, Li TK, Duann P, Liu LF. Rubin EH, et al. Cancer Treat Res. 1996;87:243-60. doi: 10.1007/978-1-4613-1267-3_10. Cancer Treat Res. 1996. PMID: 8886456 Review. No abstract available.
Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs.
Reid RJ, Benedetti P, Bjornsti MA. Reid RJ, et al. Biochim Biophys Acta. 1998 Oct 1;1400(1-3):289-300. doi: 10.1016/s0167-4781(98)00142-0. Biochim Biophys Acta. 1998. PMID: 9748633 Review.
Mechanisms of resistance to topoisomerases poisons.
Prost S. Prost S. Gen Pharmacol. 1995 Dec;26(8):1773-84. doi: 10.1016/0306-3623(95)00108-5. Gen Pharmacol. 1995. PMID: 8745168 Review.

See all similar articles

Cited by

Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro.
Sha EC, Sha MC, Kaufmann SH. Sha EC, et al. Invest New Drugs. 1996;13(4):285-94. doi: 10.1007/BF00873134. Invest New Drugs. 1996. PMID: 8824346
Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.
Sinha BK. Sinha BK. J Cancer Sci Ther. 2016;8:244-251. doi: 10.4172/1948-5956.1000421. Epub 2016 Oct 28. J Cancer Sci Ther. 2016. PMID: 31844487 Free PMC article.
Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview.
Kciuk M, Marciniak B, Kontek R. Kciuk M, et al. Int J Mol Sci. 2020 Jul 12;21(14):4919. doi: 10.3390/ijms21144919. Int J Mol Sci. 2020. PMID: 32664667 Free PMC article. Review.
Mechanisms regulating resistance to inhibitors of topoisomerase II.
Ganapathi RN, Ganapathi MK. Ganapathi RN, et al. Front Pharmacol. 2013 Aug 1;4:89. doi: 10.3389/fphar.2013.00089. eCollection 2013. Front Pharmacol. 2013. PMID: 23914174 Free PMC article.
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
Withoff S, de Vries EG, Keith WN, Nienhuis EF, van der Graaf WT, Uges DR, Mulder NH. Withoff S, et al. Br J Cancer. 1996 Dec;74(12):1869-76. doi: 10.1038/bjc.1996.647. Br J Cancer. 1996. PMID: 8980384 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database